A major difficulty in treating cancer is the inability to differentiate between normal and tumor cells. The immune system differentiates tumor from normal cells by T cell receptor (TCR) binding of tumor-associated peptides bound to Major Histocompatibility Complex (pMHC) molecules. The peptides, derived from the tumor-specific proteins, are presented by MHC proteins, which then serve as cancer markers. The TCR is a difficult protein to use as a recombinant protein because of production issues and has poor affinity for pMHC; therefore, it is not a good choice for use as a tumor identifier outside of the immune system. We constructed a synthetic antibody-fragment (Fab) library in the phage-display format and isolated antibody-fragments that bind pMHC with high affinity and specificity. One Fab, fE75, recognizes our model cancer marker, the Human Epidermal growth factor Receptor 2 (HER2/neu) peptide, E75, bound to the MHC called Human Leukocyte Antigen-A2 (HLA-A2), with nanomolar affinity. The fE75 bound selectively to E75/HLA-A2 positive cancer cell lines in vitro. The fE75 Fab conjugated with 64Cu selectively accumulated in E75/HLA-A2 positive tumors and not in E75/HLA-A2 negative tumors in an HLA-A2 transgenic mouse as probed using positron emission tomography/computed tomography (PET/CT) imaging. Considering that hundreds to thousands of different peptides bound to HLA-A2 are present on the surface of each cell, the fact that fE75 arrives at the tumor at all shows extraordinary specificity. These antibody fragments have great potential for diagnosis and targeted drug delivery in cancer.

Actinium-225 and Bi have been used successfully in targeted alpha therapy (TAT) in preclinical and clinical research. This paper is a continuation of research activities aiming to expand the availability ofAc. The high-energy proton spallation reaction on natural thorium metal targets has been utilized to produce millicurie quantities of Ac. The results of sixteen irradiation experiments of thorium metal at beam energies between 78 and 192MeV are summarized in this work. Irradiations have been conducted at Brookhaven National Laboratory (BNL) and Los Alamos National Laboratory (LANL), while target dissolution and processing was carried out at Oak Ridge National Laboratory (ORNL). Excitation functions for actinium and thorium isotopes, as well as for some of the fission products, are presented. The cross sections for production ofAc range from 3.6 to 16.7mb in the incident proton energy range of 78-192MeV. Based on these data, production of curie quantities of Ac is possible by irradiating a 5.0gcmTh target for 10 days in either BNL or LANL proton irradiation facilities.

No abstract

No abstract

The upcoming Facility for Rare Isotope Beams (FRIB) at Michigan State University provides a new opportunity to access some of the world’s most specialized scientific resources: radioisotopes. An excess of useful radioisotopes will be formed as FRIB fulfills its basic science mission of providing rare isotope beams. In order for the FRIB beams to reach high-purity, many of the isotopes are discarded and go unused. If harvested, the unused isotopes could enable new research for diverse applications ranging from medical therapy and diagnosis to nuclear security. Given that FRIB will have the capability to create about 80% of all possible atomic nuclei, harvesting at FRIB will provide a fast path for access to a vast array of isotopes of interest in basic and applied science investigations. To fully realize this opportunity, infrastructure investment is required to enable harvesting and purification of otherwise unused isotopes. An investment in isotope harvesting at FRIB will provide a powerful resource for development of crucial isotope applications. In 2010, the United States Department of Energy Office of Science, Nuclear Physics, sponsored the first ‘Workshop on Isotope Harvesting at FRIB’, convening researchers from diverse fields to discuss the scientific impact and technical feasibility of isotope harvesting. Following the initial meeting, a series of biennial workshops was organized. At the fourth workshop, at Michigan State University in 2016, the community elected to prepare a formal document to present their findings. This report is the output of the working group, drawing on contributions and discussions with a broad range of scientific experts.